DMT

TDR’s Top 5 Psychedelic Developments For The Week Of September 20

Sep 25, 2021

‘It’s A Huge Medical Need’ – Dr Routledge on Small Pharma DMT Phase 1 Completion

Sep 23, 2021

Preclinical Study Shows Microdoses Of DMT Increased Growth Of Neurons

Sep 9, 2021

California Postpones Efforts to Legalize Psychedelics Until 2022

Sep 7, 2021

Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT

Aug 27, 2021

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative…

Aug 25, 2021

Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired…

Aug 24, 2021

PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated…

Aug 16, 2021

Dr. Routledge, CMSO of Small Pharma: Psychedelics a Real Way to Treat Depression

Aug 11, 2021

Psilocybin, Ketamine, and DMT: How Do Psychedelics Work?

Aug 10, 2021